DC Bead® is an embolic Drug-Eluting Bead capable of loading and releasing chemotherapeutic agents in a controlled manner

DC Bead Introduction Brochure

 

DC Bead (DEBDOX) for Hepatocellular Carcinoma (HCC) 

DC Bead Drug-Eluting Bead with doxorubicin (DEBDOX) for Hepatocellular Carcinoma

DC Bead Drug-Eluting Bead doxorubicin (DEBDOX) in the Treatment of Hepatocellular Carcinoma (HCC), Review of Published Clinical Data); Dr Catherine Frenette

Protecting your Patients (Minimise the toxicity of TACE, for your patients and you)

DC Bead (DEBIRI) for Metastatic Colorectal Cancer

DC Bead Chemoembolisation for the Treatment of Primary (DEBDOX) and Secondary (DEBIRI) Liver Cancer, Review of Published Clinical Data; Professor Thomas Vogl

DC Bead with irinotecan, CE approved for loading with irinotecan, offering the benefits of DC Bead to more patients

Patient Information Leaflet

DC Bead Brochure Archive

Click here to view archived DC Bead Brochures

Regulatory Notices

Worldwide (excluding USA)

DC BeadM1™ is indicated for loading with irinotecan for the treatment of metastatic colorectal cancer (mCRC). For full prescribing information please refer to DC Bead M1 instructions for use.

USA

DC Bead is not currently available for sale or distribution in the USA. DC Bead has not been submitted for approval to the FDA.

Canada

DC Bead® with doxorubicin is indicated for trans-arterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC). DC Bead are also intended to be loaded with irinotecan for the purpose of embolization of vessels supplying malignant colorectal cancer metastasised to the liver (mCRC), and delivery of a local, controlled, sustained dose of irinotecan to the mCRC. For full prescribing information please refer to DC Bead Canada Instructions for Use 

Tawain

DC Bead is approved by the Department of Health and is intended to be loaded with Mayne (Hospira) doxorubicin HCI for the purpose of embolisation of vessels supplying malignant hypervascularised tumour(s), and delivery of a local, controlled, sustained dose of doxorubicin.  DC Bead is also indicated for the embolisation of nidus vessels without medication.  Approved size ranges in Taiwan are 300-500µm and 500-700µm.